posted on 2025-11-13, 18:32authored byAbisola Ave-Maria Siedoks
The objective of this thesis was to discover and develop novel therapeutic peptides. A promising, cell-permeable peptide with potential application in the treatment of type 2 diabetes mellitus was identified. This peptide could serve as a starting point for the design of a new type of anti-diabetic drug. Furthermore, the thesis employed a bioinformatic method, principal component analysis, to investigate how a superfamily of proteins and peptides function in the body. This approach will make it easier to determine how these molecules can be used as medicines.
History
Campus location
Australia
Principal supervisor
Raymond Norton
Additional supervisor 1
Martin Scanlon
Year of Award
2025
Department, School or Centre
Medicinal Chemistry
Course
Doctor of Philosophy
Degree Type
DOCTORATE
Faculty
Faculty of Pharmacy and Pharmaceutical Sciences
Rights Statement
The author retains copyright of this thesis. It must only be used for personal non-commercial research, education and study. It must not be used for any other purposes and may not be transmitted or shared with others without prior permission. For further terms use the In Copyright link under the License field.